Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Conditions
Interventions
Etrasimod
Etrasimod
+1 more
Locations
519
United States
Center for Digestive Health (Endoscopy Location)
Dothan, Alabama, United States
Digestive Health Specialists
Dothan, Alabama, United States
Dothan Eyecare-Dr. Brent McKinley (OCT Location)
Dothan, Alabama, United States
Pulmonary Associates (PFT Location)
Dothan, Alabama, United States
Flowers Hospital (Imaging Location)
Dothan, Alabama, United States
Digestive Health Specialists (Satellite Clinic Location)
Mobile, Alabama, United States
Start Date
January 6, 2020
Primary Completion Date
April 23, 2025
Completion Date
June 9, 2025
Last Updated
July 16, 2025
NCT06226883
NCT07184931
NCT06918808
NCT06647615
NCT07377188
NCT07385131
Lead Sponsor
Pfizer
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions